Talkspace, Inc. (TALK) Price Target Analysis
Updated Jul 2, 2026
Analyst Rating: Hold
Based on 10 analysts1.0% Below Target
TALK trades 1.0% below Wall Street's consensus target of $5.25.
Current Price$5.20
Average Target$5.25
Low$5.25
Median$5.25
High$5.25
Analyst Target Range
Forward P/E40.2x
(Growth Premium)
PEG Ratio—
Implied Growth—
Analyst Spread0.0%
(High Agreement)
Price Forecast (1 Year)
Last 12 months price action with 12-month analyst target path
Consensus Scenario Assumptions
The base valuation assumes TALK achieves its forward estimates and maintains a stable P/E multiple of 40.2x. This scenario reflects the blended consensus of 10 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
TALK Price Target Analysis
Updated July 8, 2026As of July 8, 2026, Talkspace, Inc. (TALK) has a Wall Street consensus price target of $5.25, based on estimates from 10 covering analysts. With the stock currently trading at $5.20, this represents a potential upside of +1.0%. The company has a market capitalization of $871M.
Analyst price targets range from a low of $5.25 to a high of $5.25, representing a 0% spread in expectations. The median target of $5.25 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 2 analysts rating the stock as a Buy or Strong Buy,8 rating it Hold, and 0 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, TALK trades at a trailing P/E of 130.0x and forward P/E of 40.2x.
Investment Context: Price targets represent analyst expectations for the next 12 months and should be considered alongside your own research. Targets are based on analysts' assumptions about earnings growth, margins, and market conditions which may change. For sector-specific context, view other Healthcare stocks.
Analyst Sentiment Comparison
Industry Peer AnalysisAvg Peer Upside
+3.1%
Industry Consensus
Avg Forward P/E
38.7x
(Growth Premium)
Peers with Coverage
10 / 10
Active Analyst Tracking
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
 OPRXOptimizeRx Corporation | $118M | $6.29 | $10.50 | +66.9% | Buy | 6.7x | 15 |
 ACMRACM Research, Inc. | $6.3B | $94.66 | $110.00 | +16.2% | Buy | 47.4x | 10 |
 MNMDMind Medicine (MindMed) Inc. | $2.0B | $20.69 | $20.00 | -3.3% | Buy | — | 1 |
 CLOVClover Health Investments, Corp. | $2.6B | $5.00 | $4.47 | -10.6% | Hold | 129.2x | 9 |
 DOCSDoximity, Inc. | $4.3B | $22.74 | $29.47 | +29.6% | Hold | 15.9x | 23 |
 TDOCTeladoc Health, Inc. | $1.6B | $9.10 | $7.40 | -18.7% | Hold | — | 42 |
 AMWLAmerican Well Corporation | $150M | $8.99 | $6.33 | -29.6% | Hold | — | 15 |
 HIMSHims & Hers Health, Inc. | $7.9B | $36.17 | $28.69 | -20.7% | Hold | — | 20 |
 GDRXGoodRx Holdings, Inc. | $1.1B | $3.03 | $3.08 | +1.7% | Hold | 9.8x | 24 |
 UNHUnitedHealth Group Incorporated | $388.9B | $428.19 | $426.75 | -0.3% | Buy | 23.3x | 52 |
TALK — Frequently Asked Questions
Quick answers to the most common questions about buying TALK stock.
What is the TALK stock price target for 2026?
The consensus price target for TALK is $5.25, close to the current price of $5.2 (1.0% implied move). Based on 10 analyst estimates, the stock appears fairly valued near current levels.
Is TALK a buy, sell, or hold?
TALK has a consensus rating of "Hold" based on 10 Wall Street analysts. The rating breakdown is mixed, with 8 Hold ratings making up the largest segment. The consensus 12-month price target of $5.25 implies 1.0% upside from current levels.
Is TALK stock overvalued or undervalued?
At a forward P/E of 40.2166x, TALK trades at a premium valuation. The consensus price target of $5.25 (1.0% upside) suggests analysts may view current valuations as stretched.
How high can TALK stock go?
The most bullish Wall Street analyst has a price target of $5.25 for TALK, while the most conservative target is $5.25. The consensus of $5.25 represents the median expectation. These targets typically reflect 12-month expectations.
How many analysts cover TALK stock?
TALK is moderately covered, with 10 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 2 have Buy ratings, 8 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
What is the TALK stock forecast?
The 12-month TALK stock forecast based on 10 Wall Street analysts shows a consensus price target of $5.25, with estimates ranging from $5.25 (bear case) to $5.25 (bull case). The median consensus rating is "Hold".
What is TALK's forward P/E ratio?
TALK trades at a forward P/E ratio of 40.2x based on next-twelve-months earnings estimates compared to a trailing P/E of 130.0x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Should I buy TALK stock?
TALK appears fairly valued according to analysts, with a "Hold" rating and minimal upside to the $5.25 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
Why do TALK price targets vary so much?
TALK analyst price targets range from $5.25 to $5.25, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $5.25 consensus represents the middle ground.
Consensus-Based Analysis Tools
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Check Valuation
Historical Returns
10-year return with dividends reinvested.
Calculate
DCA Calculator
See how regular investing compounds over time.
Run Numbers
Peer Comparison
Compare growth, multiples, and margins vs sector.
Compare